This news article was originally written in Spanish. It has been automatically translated for your convenience. Reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace a human translator. The original article in Spanish can be viewed at BIO-Europe Spring 2010 convertirá Barcelona en la capital europea de la biotecnología
BIO-Europe Spring 2010 Barcelona become the European capital of biotechnology
20/01/2010
January 20, 2010
Between 8 and 10 March 2010, Barcelona will host in the Centre of International Convention (CCIB) one of the most important congresses of biotechnology partnership at the international level, the BIO-Europe Spring 2010. The event is organized by EBD Group and Biocat, which coordinates the Local Host Committee, composed of the Generalitat de Catalunya (through its departments of Vice-President, economy and finance, health and DIUE), ACC1Ó, City Council of Barcelona, Cambra de Comerç de BarcelonaGenome Spain, Asebio, Invest in Spain and the Fundació Catalana per a the Recerca i la Innovació (FCRI).
Barcelona's BIO-Europe Spring will include the sponsorship of Catalan companies and Almirall, Amgen, Esteve, GP Pharm, Oryzon, Palau Pharma Ysios Capital Partners, among others, and assist companies and entities biotechnological, pharmaceutical, financial and business services from around the world. The Congress aims to these companies and participating entities can meet investors and potential partners, close partnerships, boost markets and promote the biotechnological sector in their respective regions of origin. It is expected that during the Congress should be held more than 7,000 one-to-one meetings that will facilitate the achievement of these objectives.
